Aβ-degrading endopeptidase, neprilysin, in mouse brain:: synaptic and axonal localization inversely correlating with Aβ pathology

被引:127
作者
Fukami, S
Watanabe, K
Iwata, N
Haraoka, J
Lu, B
Gerard, NP
Gerard, C
Fraser, P
Westaway, D
St George-Hyslop, P
Saido, TC
机构
[1] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama 3510198, Japan
[2] Tokyo Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1600023, Japan
[3] Harvard Univ, Sch Med, Dept Pediat & Med, Boston, MA 02115 USA
[4] Univ Toronto, Ctr Res Neurodegenerate Dis, Toronto, ON M5S 1A1, Canada
[5] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A1, Canada
[6] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A1, Canada
[7] Univ Toronto, Dept Med, Toronto, ON M5S 1A1, Canada
[8] Univ Hlth Network, Dept Med, Div Neurol, Toronto, ON, Canada
基金
加拿大健康研究院;
关键词
Alzheimer's disease; amyloid-beta peptide; neprilysin; immunofluorescence; brain aging; hippocampus;
D O I
10.1016/S0168-0102(02)00015-9
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Metabolism of amyloid-beta peptide (Abeta) is closely associated with the pathology and etiology of Alzheimer's disease (AD). Since neprilysin is the only rate-limiting catabolic peptidase proven by reverse genetics to participate in Abeta metabolism in vivo, we performed detailed immunohistochemical analysis of neprilysin in mouse brain using neprilysin-deficient mice as a negative control. The aim was to assess, at both the cellular and subcellular levels, where Abeta undergoes neprilysin-dependent degradation in the brain and how neprilysin localization relates to Abeta pathology in amyloid precursor protein (APP)-transgenic mice. In hippocampus, neprilysin was present in the stratum pyramidale and stratum lacunosum-moleculare of the CA1-3 fields and the molecular layer of the dentate gyrus. Confocal double immunofluorescence analyses revealed the subcellular localization of neprilysin along axons and at synapses. This observation suggests that after synthesis in the soma, neprilysin, a type IT membrane-associated protein, is axonally transported to the terminals, where Abeta degradation is likely to take place. Among various cell types, GABAergic and metabotropic glutamate 2/3 receptor-positive neurons but not catecholaminergic or cholinergic neurons, expressed neprilysin in hippocampus and neocortex, implying the presence of a cell type-specific mechanism that regulates neprilysin gene expression. As expected, Abeta deposition correlated inversely with neprilysin expression in TgCRND8 APP-transgenic mice. These observations not only support the notion that neprilysin functions as a major AD-degrading enzyme in the brain but also suggest that down-regulation of neprilysin activity, which may be caused by aging, is likely to elevate local concentrations of Abeta at and around neuronal synapses. (C) 2002 Elsevier Science Ireland Ltd and the Japan Neuroscience Society. All rights reserved.
引用
收藏
页码:39 / 56
页数:18
相关论文
共 75 条
  • [1] Immunohistochemical localization of neprilysin in the human cerebral cortex:: inverse association with vulnerability to amyloid β-protein (Aβ) deposition
    Akiyama, H
    Kondo, H
    Ikeda, K
    Kato, M
    McGeer, PL
    [J]. BRAIN RESEARCH, 2001, 902 (02) : 277 - 281
  • [2] BACK SA, 1989, J NEUROSCI, V9, P4439
  • [3] DIFFERENTIAL EXPRESSION OF SYNAPTIC VESICLE PROTEIN-2 (SV2) ISOFORMS
    BAJJALIEH, SM
    FRANTZ, GD
    WEIMANN, JM
    MCCONNELL, SK
    SCHELLER, RH
    [J]. JOURNAL OF NEUROSCIENCE, 1994, 14 (09) : 5223 - 5235
  • [4] BINDER LI, 1985, J CELL BIOL, V101, P1371, DOI 10.1083/jcb.101.4.1371
  • [5] Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins
    Borchelt, DR
    Ratovitski, T
    vanLare, J
    Lee, MK
    Gonzales, V
    Jenkins, NA
    Copeland, NG
    Price, DL
    Sisodia, SS
    [J]. NEURON, 1997, 19 (04) : 939 - 945
  • [6] Familial Alzheimer's disease-linked presenilin 1 variants elevate A beta 1-42/1-40 ratio in vitro and in vivo
    Borchelt, DR
    Thinakaran, G
    Eckman, CB
    Lee, MK
    Davenport, F
    Ratovitsky, T
    Prada, CM
    Kim, G
    Seekins, S
    Yager, D
    Slunt, HH
    Wang, R
    Seeger, M
    Levey, AI
    Gandy, SE
    Copeland, NG
    Jenkins, NA
    Price, DL
    Younkin, SG
    [J]. NEURON, 1996, 17 (05) : 1005 - 1013
  • [7] Bornemann KD, 2001, AM J PATHOL, V158, P63, DOI 10.1016/S0002-9440(10)63945-4
  • [8] NEUROPATHOLOGICAL STAGING OF ALZHEIMER-RELATED CHANGES
    BRAAK, H
    BRAAK, E
    [J]. ACTA NEUROPATHOLOGICA, 1991, 82 (04) : 239 - 259
  • [9] BUCKLEY K, 1985, J CELL BIOL, V100, P1284, DOI 10.1083/jcb.100.4.1284
  • [10] Buxbaum JD, 1998, J NEUROSCI, V18, P9629